Suwanee, GA, United States of America

Thomas Edward Godfrey

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas Edward Godfrey: Innovator in Ocular Drug Delivery

Introduction

Thomas Edward Godfrey is a notable inventor based in Suwanee, GA (US). He has made significant contributions to the field of ocular drug delivery, holding 2 patents that showcase his innovative approach to medical technology.

Latest Patents

His latest patents include "Systems and methods for ocular drug delivery" and "Ocular injection kit, packaging, and methods of use." The first patent describes devices, methods, and kits designed for ocular drug delivery. This apparatus features a housing that contains an energy storage member, a barrel, and a hub. The barrel is configured to hold medicament and includes a piston and an elastomeric member. The design allows for the production of a fluid jet to access target locations within the eye. The second patent outlines an ocular injection kit that includes a first tray member, a second tray member, and a lid. This kit is constructed to maintain the sterility of the medicament and includes features to securely retain an ocular injector.

Career Highlights

Thomas Edward Godfrey is currently associated with Clearside Biomedical, Inc., where he continues to develop innovative solutions in ocular drug delivery. His work has the potential to significantly improve patient outcomes in eye care.

Collaborations

He collaborates with talented individuals such as Rafael Victor Andino and Shelley Eckert Hancock, contributing to a dynamic team focused on advancing ocular health technologies.

Conclusion

Thomas Edward Godfrey's contributions to ocular drug delivery through his patents and work at Clearside Biomedical, Inc. highlight his role as an influential inventor in the medical field. His innovative designs are paving the way for improved treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…